Dendritic Cells DCVAC/PCa
Sponsors
SOTIO a.s.
Conditions
Prostate CancerProstate Cancer Metastatic
Phase 2
Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
CompletedNCT02105675
Start: 2012-02-29End: 2017-02-20Target: 60Updated: 2017-05-24
Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer
CompletedNCT02107430
Start: 2012-03-31End: 2018-10-31Updated: 2018-11-14
Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer
CompletedNCT02107404
Start: 2012-04-30End: 2017-05-22Target: 150Updated: 2017-05-24
Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer
CompletedNCT02107391
Start: 2012-03-31End: 2016-06-30Updated: 2017-05-24
Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer
CompletedNCT02137746
Start: 2013-12-31End: 2017-03-20Updated: 2017-05-24